That's only the broker options. Look at the 3B, and you'll see there's a total of 145m options outstanding.
The [email protected] is for the CEO and has conditions on when they can be exercised.
All told, if we assume they all get converted, we're in a potential cash position of $10m, which should last at least 2 years one would think if we're going at a rate of $4m/yr. I imagine we'll have revenue coming in by then via licensing agreements, so hopefully we've seen the last of any capital raisings.
Column 1 Column 2 Column 3 Column 4 Column 5 0 {colgroup} 1 {col=140x@}{/col}{col=100x@}{/col}{col=100x@}{/col}{col=100x@}{/col}{col=100x@}{/col} 2 {/colgroup} 3 Number Price Value Expiry 4 Options 5,000,000 $0.05000 $250,000 16-Sep-2018 5 50,000,000 $0.06250 $3,125,000 1-Aug-2019 6 62,289,998 $0.03000 $1,868,700 30-Jun-2020 7 28,000,000 $0.01755 $491,400 1-Oct-2021 8 Total Options 145,289,998 $5,735,100 9 10 11 Cash held $4,538,443 12 13 TOTAL POTENTIAL CASH $10,273,543
In all, we've got world class technology, a world class management team, exponentially growing market expected to be worth $100B in the not too distant future. Take advantage of the low prices while you can, it's a strong buy for me.
- Forums
- ASX - By Stock
- WBT
- Ann: Appendix 4D & Interim Financial Report - 31 Dec 2017
Ann: Appendix 4D & Interim Financial Report - 31 Dec 2017, page-14
Featured News
Add WBT (ASX) to my watchlist
|
|||||
Last
$2.39 |
Change
-0.050(2.05%) |
Mkt cap ! $451.1M |
Open | High | Low | Value | Volume |
$2.50 | $2.51 | $2.38 | $1.134M | 468.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 46834 | $2.38 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.43 | 16564 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 46834 | 2.380 |
4 | 9648 | 2.370 |
4 | 13792 | 2.360 |
9 | 12289 | 2.350 |
2 | 4456 | 2.340 |
Price($) | Vol. | No. |
---|---|---|
2.430 | 16564 | 2 |
2.450 | 8000 | 1 |
2.460 | 7551 | 1 |
2.480 | 2015 | 1 |
2.500 | 12000 | 1 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
WBT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online